TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
XBIT

XBiotech Inc

Healthcare · Biotechnology

2.20$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement XBIT
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – +247.0% -58.2% -78.2% -92.5% -100.0% –
– -17.1% -15.3% +5.3% -0.1% +112.6% +63.9% -3.0% +1,363.3% -83.2% -88.8% +167.9% +0.1% -3.4%
– – – – – – – – – +33.1% -73.3% -151.9% – –
– -40.5% +80.6% +118.5% +35.7% -37.8% -40.5% +53.2% -60.5% +196.7% +11.6% +4.1% +14.9% +25.5%
– +8.8% +274.3% -16.8% +65.8% -25.7% -31.0% +35.6% +154.8% -48.4% -32.8% -26.1% +1.1% +76.0%
– -35.7% +131.0% +74.3% +41.4% -37.4% -43.0% +55.6% -4.0% +35.8% +0.5% -0.9% +13.2% +27.1%
– – – – – – – – – – – – – –
– – – – – – – – -98.8% -87.8% -17.0% -100.0% – -89.1%
– – – – – – – – -101.8% – – – – –
– – -2,800.0% – – – – – -103.2% – – – -113.1% –
– – – – – – – – -101.7% – – – – –
– – – – – – – – -102.2% – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?